Liminatus Pharma, Inc.
LIMNNasdaqCIK 1971387HealthcareFiscal year ends Dec 31
Reports and events: 38 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2905:15 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-111665 |
| 2026-08-1816:06 ET | 8-K | 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-098335 |
| 2026-08-1416:51 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-097304 |
| 2026-08-0416:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-090423 |
| 2026-07-3021:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088380 |
| 2026-07-2416:51 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-086674 |
| 2026-07-1417:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-083585 |
| 2026-07-1308:43 ET | DEF 14A | Proxy statementPeriod 2026-08-03 | 0001104659-26-082905 |
| 2026-07-0609:13 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-080613 |
| 2026-06-2421:28 ET | S-1 | Registration statement | 0001104659-26-076958 |
| 2026-06-0317:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-070173 |
| 2026-05-2716:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-26-066974 |
| 2026-05-2017:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-064585 |
| 2026-05-1516:49 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-062734 |
| 2026-03-3117:28 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-037933 |
| 2026-03-0416:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-023467 |
| 2026-02-1817:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-017134 |
| 2026-02-1106:08 ET | S-1 | Registration statement | 0001104659-26-012942 |
| 2026-02-0915:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-012016 |
| 2026-01-2616:31 ET | 8-K | 3.01 Delisting notice | 0001104659-26-006619 |
| 2025-11-2517:26 ET | 8-K | 3.01 Delisting notice | 0001104659-25-116049 |
| 2025-11-1421:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-111651 |
| 2025-10-0621:53 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001104659-25-096872 |
| 2025-08-2517:15 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-25-082579 |
| 2025-08-1416:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-078577 |
| 2025-07-2821:59 ET | S-1/A | Registration statement, amended | 0001410578-25-001518 |
| 2025-07-1716:19 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001104659-25-068670 |
| 2025-07-1117:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-067444 |
| 2025-07-0311:40 ET | 8-K | 8.01 Other events | 0001104659-25-065663 |
| 2025-06-2416:49 ET | S-1 | Registration statement | 0001410578-25-001432 |
| 2025-06-2415:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-062058 |
| 2025-06-2406:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061875 |
| 2025-06-0416:31 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-25-056421 |
| 2025-06-0221:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001410578-25-001388 |
| 2025-06-0221:43 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-25-055078 |
| 2025-05-0816:21 ET | SCHEDULE 13D | Ownership report, active investor | 0001200876-25-000020 |
| 2025-05-0717:11 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-045628 |
| 2025-05-0617:20 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-045127 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.